Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Conflict of interest JD is a paid consultant for the Stryker Corporation, has intellectual property rights with Elucida Oncology and equity interest in Welwaze Medical, LLC, and has a royalty agreement with Springer Publishers for Multimodal Management of Upper and Lower Extremity Lymphedema
120(1): p
Patients without coverage face the full retail price
BoNT/X protease cleaves VAMP1 between Arg 68 and Ala 69, and notable de-enrichment at Ala 69 and Asp 70, along with slight de-enrichment at Arg 68 in the substrate profile, suggests that P1, P1 and P2 primarily dictate BoNT/X protease substrate recognition (Fig
Johns wort, a nutritional supplement, may interact with it, raising the risk of serotonin syndrome
US$ 21.91
US$ 25.00
US$ 26.87
US$ 27.57
US$ 20.33
